Status:
ACTIVE_NOT_RECRUITING
Effect of Exercise in Head and Neck Cancer Patients
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Collaborating Sponsors:
Kom Op Tegen Kanker
Conditions:
Head and Neck Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Head and neck cancers (HNC) are malignancies originating from the mucosa in the oral cavity, nasopharynx, oropharynx, hypopharynx and larynx. Unfortunately, the majority of patients with HNC have loca...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years
- Diagnosed with primary malignant tumour head and neck region (oral cavity, nasal cavity and paranasal sinuses, pharynx, larynx, salivary glands, thyroid)
- ECOG performance score 0-1
- Planned for curative (chemo)radiotherapy
- Able to complete baseline assessments prior to start of radiotherapy.
- Physically and mentally capable of taking part in an exercise program and motivated to engage in a supervised exercise program.
Exclusion
- Patients \< 18 years
- ECOG ≥ 2
- Patient with HNC, treated with palliative intent
- Evidence of distant metastases
Key Trial Info
Start Date :
January 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05256238
Start Date
January 25 2022
End Date
December 1 2025
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Leuven
Leuven, Belgium, 3000